✦ LIBER ✦

Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the radiation therapy oncology group 92-10

✍ Scribed by Perry W Grigsby; J.D Lu; David G Mutch; Robert Y Kim; Patricia J Eifel

Book ID: 108437123
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 57 KB
Volume: 41
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(98)00132-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twice-daily fractionation of external ir

Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the radiation therapy oncology group 88—05

✍ Ritsuko Komaki; Thomas F. Pajak; Victor A. Marcial; Marvin Rotman; Perry W. Grig 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

1.9% at 1 year, and 6.3% at 2 and 3 years. Of 80 patients evaluated for response, 80% had complete disappearance of disease. Comparisons with historical rates of late toxicity with standard fractionation (STD) revealed similar results in spite of higher total doses with HFX. Comparisons between hist

A Phase I/II study of external beam radi

A Phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207) : Final report

✍ Laurie E. Gaspar; Kathryn Winter; Walter I. Kocha; Lawrence R. Coia; Arnold Hers 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Background: A multiinstitutional, prospective study of the radiation therapy oncology group (rtog) was designed to determine the feasibility and toxicity of chemotherapy, external beam radiation, and esophageal brachytherapy (eb) in a potentially curable group of patients with adenocarcinoma or